Prevalence and Factors Associated With CKD: A Population Study From Beijing

American Journal of Kidney Diseases

Volumn 51, Issue 3, 2008, Pages 373-384

  Zhang, LuXia ^a   Zhang, PuHong ^b   Wang, Fang ^a   Zuo, Li ^a   Zhou, Ying ^b   Shi, Ying ^b   Li, Gang ^b   Jiao, ShuFang ^b   Liu, ZeJun ^b   Liang, WanNian ^c   Wang, HaiYan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Beijing Municipal Health Bureau   (China)

Author keywords

albuminuria; China; Chronic kidney disease; kidney function; screening

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHINA; CHRONIC KIDNEY DISEASE; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HEPATITIS B; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIMPSON GOLABI BEHMEL SYNDROME; SMOKING; URBAN RURAL DIFFERENCE;

ADULT; AGED; ALBUMINURIA; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HEMATURIA; HUMANS; MALE; MEDICINE, HERBAL; MIDDLE AGED; ODDS RATIO; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 39449123286     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.11.009     Document Type: Article

References (51)

1. Lysaght M.J. Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol 13 suppl 1 (2002) S37-S40
2. Vanholder R., Massy Z., Argiles A., et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20 (2005) 1048-1056
3. Parfrey P.S., and Foley R.N. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10 (1999) 1606-1615
4. Foley R.N., Parfrey P.S., and Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 suppl 3 (1998) S112-S119
5. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
6. Dirks J.H., De Zeeuw D., Agarwal S.K., et al. Prevention of chronic kidney and vascular disease: Toward global health equity-The Bellagio 2004 Declaration. Kidney Int Suppl 98 (2005) S1-S6
7. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
8. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
9. Chadban S.J., Briganti E.M., Kerr P.G., et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 14 suppl 2 (2003) S131-S138
10. Hallan S.I., Coresh J., Astor B.C., et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17 (2006) 2275-2284
11. Chen J., Wildman R.P., Gu D., et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int 68 (2005) 2837-2845
12. Zhang L., Zuo L., Xu G., et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant 22 (2007) 1093-1099
13. Dialysis and Transplantation Registration Group CSoNCMA. The report about the registration of dialysis and transplantation in China 1999. Chin J Nephrol 17 (2001) 77-78
14. Fourth National Health and Nutrition Examination Survey Working Group. Results from the Fourth National Health and Nutrition Examination Survey of China. Acta Nutr Sin 26 (2004) 417-420
15. Liu L.S., Chen M.Q., Zeng G.Y., et al. A forty-year study on hypertension. Acta Acad Med Sin 24 (2002) 401-408
16. Wu Y.K., Lu C.Q., and Gao R.Q. Nation-wide hypertension screening in China during 1979-1980. Chin Med J 95 (1982) 101-108
17. Hooi L.S., Wong H.S., and Morad Z. Prevention of renal failure: The Malaysian experience. Kidney Int Suppl 94 (2005) S70-S74
18. Tungsanga K., Ratanakul C., Pooltavee W., et al. Experience with prevention programs in Thailand. Kidney Int Suppl 94 (2005) S68-S69
19. Mani M.K. Experience with a program for prevention of chronic renal failure in India. Kidney Int Suppl 94 (2005) S75-S78
20. Ma Y.C., Zuo L., Chen J.H., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2937-2944
21. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: Programs and collection procedures. Vital Health Stat 32 (1994) 11-407
22. Coresh J., Astor B.C., Greene T., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 2 (2002) S1-S266 (suppl 1)
24. Zuo L., and Wang M. Current status of hemodialysis treatment in Beijing, China. Ethn Dis 16 suppl 2 (2006) S2-S4
25. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16 (2005) 180-188
26. Hallan S.I., Coresh J., Astor B.C., et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17 (2006) 2275-2284
27. United Nations, Economic and Social Development: World population prospects: the 2006 version. http://esa.un.org/unpp/p2k0data.asp Accessed September 5, 2007
28. Brancati F.L., Whelton P.K., Randall B.L., et al. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 278 (1997) 2069-2074
29. Tozawa M., Iseki K., Iseki C., et al. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 41 (2003) 1341-1345
30. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 (1996) 13-18
31. Klag M.J., Whelton P.K., Randall B.L., et al. End-stage renal disease in African-American and white men. 16-Year MRFIT findings. JAMA 277 (1997) 1293-1298
32. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
33. Ong K.L., Cheung B.M., Man Y.B., et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49 (2007) 69-75
34. PRC National Blood Pressure Survey Cooperative Group. Hypertension prevalence and the status of people awareness, treatment and control in China: A national-wide survey in 1991. Chin J Hypertens 3 suppl 1 (1995) S14-S18
35. Gu D., Reynolds K., Wu X., et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 40 (2002) 920-927
36. Xiang H., Wu W., and Liu C. A epidemiological study on DM 1995-1996 in China. Chin J Diabetes 6 (1998) 131-133
37. Wirta O.R., Pasternack A.I., Mustonen J.T., et al. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Nephrol Dial Transplant 11 (1996) 449-456
38. Vanherweghem J.L., Depierreux M., Tielemans C., et al. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391
39. Li X., and Wang H. Aristolochic acid nephropathy: What we know and what we have to do. Nephrology (Carlton) 9 (2004) 109-111
40. Brunner F.P., and Selwood N.H. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee. Nephrol Dial Transplant 9 (1994) 1371-1376
41. Schwarz A., Preuschof L., and Zellner D. Incidence of analgesic nephropathy in Berlin since 1983. Nephrol Dial Transplant 14 (1999) 109-112
42. De Smet P.A. Herbal remedies. N Engl J Med 347 (2002) 2046-2056
43. Barrett B., Kiefer D., and Rabago D. Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. Altern Ther Health Med 5 (1999) 40-49
44. Barsoum R.S. End-stage renal disease in North Africa. Kidney Int Suppl 94 (2003) S111-S114
45. Plata R., Silva C., Yahuita J., et al. The first clinical and epidemiological programme on renal disease in Bolivia: A model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial Transplant 13 (1998) 3034-3036
46. Li P.K., Kwan B.C., Leung C.B., et al. Prevalence of silent kidney disease in Hong Kong: The screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl 94 (2005) S36-S40
47. Hall C.L., Bradley R., Kerr A., et al. Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria. Clin Nephrol 62 (2004) 267-272
48. Topham P.S., Harper S.J., Furness P.N., et al. Glomerular disease as a cause of isolated microscopic haematuria. Q J Med 87 (1994) 329-335
49. Liu G., Ma X.Z., Zou W.Z., et al. The prevalence of biopsy-proven renal diseases in adults between two periods over the past 10 years. J Clin Intern Med 21 (2004) 834-838
50. Szeto C.C., Lai F.M., To K.F., et al. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 110 (2001) 434-437
51. Centers for Disease Control and Prevention. Incidence of end-stage renal disease among persons with diabetes-United States 1990-2002. MMWR Morbid Mortal Wkly Rep 54 (2005) 1097-1100